292, 207231 [DOI] [PMC free article] [PubMed] [Google Scholar] Dziegielewska K
Considerations and Future Research While early research on BPC-157 is promising, more studies are needed to fully understand its long-term effects and safety profile, particularly in the context of gut health
Journal (Drug Design, Development and Therapy, Apr 30, 2015, 9, 24852499)
BPC-157 constitutes 62.5% of the total 80mg blend by mass, reflecting both its studied dose-dependency in preclinical models and its relatively higher molecular weight (~1,419 Da) compared to KPV (~340 Da) and GHK (~340 Da)
Consistent with this observation, decreased TNF-stimulated IB- phosphorylation was observed in hepatocytes with elevated GSSG levels